KALA BIO
Development and commercialization of therapeutics using our proprietary nanoparticle-based Mucus Penetrating Particles.
Launch date
Employees
Market cap
AUD50.1m
Enterprise valuation
AUD23m (Public information from Sep 2024)
Share price
$5.79 KALA
Waltham Massachusetts (HQ)
Authorizing premium user...